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Abstract
Background: β-catenin and transforming growth factor β signaling are activated in fibroblasts
during wound healing. Both signaling pathways positively regulate fibroblast proliferation during this
reparative process, and the effect of transforming growth factor β is partially mediated by β-
catenin. Other cellular processes, such as cell motility and the induction of extracellular matrix
contraction, also play important roles during wound repair. We examined the function of β-catenin
and its interaction with transforming growth factor β in cell motility and the induction of collagen
lattice contraction.
Results: Floating three dimensional collagen lattices seeded with cells expressing conditional null
and stabilized β-catenin alleles, showed a modest negative relationship between β-catenin level and
the degree of lattice contraction. Transforming growth factor β had a more dramatic effect,
positively regulating lattice contraction. In contrast to the situation in the regulation of cell
proliferation, this effect of transforming growth factor β was not mediated by β-catenin. Treating
wild-type cells or primary human fibroblasts with dickkopf-1, which inhibits β-catenin, or lithium,
which stimulates β-catenin produced similar results. Scratch wound assays and Boyden chamber
motility studies using these same cells found that β-catenin positively regulated cell motility, while
transforming growth factor β had little effect.
Conclusion:  This data demonstrates the complexity of the interaction of various signaling
pathways in the regulation of cell behavior during wound repair. Cell motility and the induction of
collagen lattice contraction are not always coupled, and are likely regulated by different intracellular
mechanisms. There is unlikely to be a single signaling pathway that acts as master regulator of
fibroblast behavior in wound repair. β-catenin plays dominant role regulating cell motility, while
transforming growth factor β plays a dominant role regulating the induction of collagen lattice
contraction.
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Background
Wound healing proceeds through overlapping inflamma-
tory, proliferative and remodeling phases. During the pro-
liferative phase of wound healing, activated fibroblasts
induce contraction of the healing wound, move across tis-
sue defects to provide mechanical stability, and act to
reorganize the extracellular matrix [1]. These cells persist
in hyperplastic wounds and other conditions in which
excessive scarring occurs, and as such an understating of
their behavior has important practical implications in
developing therapies for disorders of wound healing.
Although the phenomenon of wound contraction and the
reorganization of the extracellular matrix are well recog-
nized, the cellular mechanisms regulating the processes
are incompletely understood. These cell processes can be
modeled in-vitro by observing the ability of cells to cause
contraction of a three-dimensional collagen lattice.
Fibroblasts from actively healing wounds have an
enhanced ability to cause contraction in these lattices. In
the floating collagen lattice contraction assay the ability of
fibroblasts to reorganize collagen matrices can be
observed[2]. Wound fibroblasts move across the tissue
defect to reconstitute the mechanical properties of the
damaged tissues[3], a process that can be measured in-
vitro using a scratch assay [4-6]. Although several factors
are known to regulate fibroblast cell motility, most have
been investigated in the context of chemotaxis, using
Boyden chambers to measure how they move towards
specific agent[7], and there are only a few studies investi-
gating the role of external factors and signaling pathways
on fibroblast motility across an injury defect using the
scratch assay [5,6].
Transforming growth factor β ligands act through Smad
transcription factors to regulate gene expression. These
growth factors are expressed during the initial phases of
wound repair. Injection of transforming growth factor β –
one into cutaneous wounds causes a larger sized wound,
and absence of the transforming growth factor β regulated
transcription factor, Smad3, results in early wound closure
with a smaller wound size [8-10]. Transforming growth fac-
tor β – one also enhances the ability of fibroblasts to cause
lattice contraction in-vitro [11]. In contrast, its role in mod-
ulating fibroblast motility in wound repair is unclear, as
although it is demonstrated to act as a chemoattractant for
fibroblasts, it has also been shown to inhibit fibroblast
motility under other conditions [7,12,13].
Fibroblast-like cells in the dermal compartment of the
healing skin during the proliferative phase of wound heal-
ing, exhibit high levels of β-catenin protein, and activa-
tion of β-catenin mediated tcf dependent transcriptional
activity [14,15]. During the normal remodeling phase, β-
catenin levels return to baseline, but in human hyperplas-
tic wounds, β-catenin levels remain elevated for a pro-
longed duration. Studies using genetically modified mice
found that β-catenin level correlates with the size of cuta-
neous wounds. [14,16,17]. β-catenin is a key mediator of
the canonical Wnt (wingless) signaling pathway. Canoni-
cal Wnt signaling activation results in the stabilization of
β-catenin protein. Stabilized cytosolic β-catenin translo-
cates into the nucleus, where it binds to tcf-lef family pro-
teins to form a transcriptional activation complex. Tcf-lef
family members are architectural transcription factors,
changing DNA conformation when activated. [18-20]. β-
catenin also interacts with E-cadherin, and mediates the
interplay of adherens junction molecules and the actin
cytoskeleton[21]. Stabilization of β-catenin in fibroblast
cell cultures increases cell proliferation and invasiveness
[15,22,23].
β-catenin has an important role in wound healing. It also
mediates the effect of transforming growth factor β in reg-
ulating proliferation during wound repair [14,16,17]. As
such, it is possible that β-catenin plays a similar role in the
regulation of lattice contraction and cell motility during
wound repair. We thus examined the role that transform-
ing growth factor β and β-catenin play regulating cell
motility and the induction of collagen lattice contraction
in primary mouse and human fibroblast cultures.
Results
β-catenin negatively regulates the induction of collagen 
lattice contraction
Primary dermal fibroblast cell cultures were established
from mice expressing conditional null or stabilized alleles
of β-catenin, and wild type littermates. To activate the
conditional alleles, cells were treated with an adenovirus
engineered to expresses cre-recombinase[16]. Cells from
wild-type mice were also treated with the same adenovi-
rus. Western analysis confirmed the expected difference in
β-catenin levels between the samples, with two bands
identified for the stabilized form of β-catenin, represent-
ing the slightly smaller protein size generated by the con-
ditional allele lacking exon three (Fig. 1C) [24]. Using
relative densitometry (to the control protein GAPDH),
there was an observed decrease in β-catenin in cells in
which the null allele was activated to 32% of control val-
ues (p < 0.005), and an increase in β-catenin in levels in
cells expressing the stabilized allele to 230% of control
value (P < 0.001). There was an observed progressive con-
traction of the floating collagen lattices over a seven-day
period. There was no difference in the rate of lattice con-
traction between primary dermal fibroblasts derived from
wild type mice and those from mice expressing the condi-
tional alleles, but whose alleles had not activated. In cells
expressing a stabilized form of β-catenin there was a
slightly decreased rate of lattice contraction, while in cells
expressing a null form of β-catenin, there was a slightly
increased contraction rate when examined in serum free
media (Fig. 1A and 1B). The same experiment was per-
formed using media containing serum, and a greater rateBMC Cell Biology 2009, 10:38 http://www.biomedcentral.com/1471-2121/10/38
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of lattice contraction was seen. There was a slightly greater
difference in the rate of induction of collagen lattice con-
traction observed between cells from mice expressing null
and stabilized alleles than in experiments undertaken in
serum free media (Fig. 1D). To ensure that changes in β-
catenin levels did not alter cell numbers, which might
change the rate of lattice contraction, we examined the
number of cells present using DNA content, and found no
difference in cell numbers between the various lattices.
Transforming growth factor β induced lattice contraction 
at a substantially greater rate than deficiency in β-catenin
Transforming growth factor β one is known to induce con-
traction of three dimensional collagen lattices seeded with
fibroblasts [11]. Since β-catenin partially mediates trans-
forming growth factor β regulated fibroblast cell prolifer-
ation[16], we examined if transforming growth factor β
induced collagen lattice contraction might be mediated by
β-catenin. Contraction rate was compared between wild
type and β-catenin null cells treated with transforming
growth factor β. The effect of transforming growth factor β
induced lattice contraction was not dependent β-catenin
(Fig. 2). The relationship of β-catenin stabilization and
transforming growth factor β treatment was examined in
cells expressing stabilized β-catenin alleles. There was a
small effect of β-catenin stabilization compared to trans-
forming growth factor β treatment (Fig. 3). In contrast to
its role in fibroblast proliferation, transforming growth
Collagen lattice contraction is negatively regulated by β-catenin Figure 1
Collagen lattice contraction is negatively regulated by β-catenin. A. Means and 95% confidence intervals for collagen 
lattice mean diameter as observed over seven days are given for fibroblasts from mice expressing the wild type, null, or stabi-
lized β-catenin alleles, all treated with the adenovirus expressing cre recombinase in the absence of serum. There is a statisti-
cally significant difference between the stabilized and wild type cells for the time points with an asterisk below the data points. 
B. Representative photograph of the collagen lattices at day five. C. Western analysis for β-catenin showing successful recom-
bination in the fibroblasts in the lattices. D. Means and 95% confidence intervals for collagen lattice mean diameter as observed 
over seven days are given for fibroblasts from mice expressing the wild type, null, or stabilized β-catenin alleles, all treated with 
the adenovirus expressing cre recombinase in the presence of serum. There is a statistically significant difference between 
either the stabilized or null cells and wild type cells at the time points with an asterisk either above or below the data points.BMC Cell Biology 2009, 10:38 http://www.biomedcentral.com/1471-2121/10/38
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factor β induces contraction of collagen lattices independ-
ent of β-catenin.
Lithium and DKK-1 treatment produce similar effects as 
expression of conditional β-catenin null or stabilized 
alleles
Lithium will elevate β-catenin level through its regula-
tion of GSK3β [25,26], and dickkopf-1 (Dkk-1) ligand
will inhibit Wnt receptor binding, preventing the activa-
tion of β-catenin catenin mediated signaling by receptor
activation [27,28]. We treated fibroblasts with an adeno-
virus expressing Dkk-1 [29] and observed their ability of
TGF-β to induce lattice contraction. Cell cultures
infected with Ad-Dkk-1 demonstrated the same behavior
as fibroblasts expressing conditional null alleles of β-cat-
enin (Fig. 4). To determine if lithium could induce
fibroblasts to cause lattice contraction, we treated wild
type and β-catenin null cells with lithium. Lithium treat-
ment induced β-catenin protein, and inhibited lattice
contraction in wild type cell, in a similar manner to that
observed in cells expressing β-catenin stabilized condi-
tional alleles (Fig. 4). Lithium and Dkk-1 treatment had
no effect on cells expressing null alleles of β-catenin.
Using densitometry there was an increase to 195% of
baseline β-catenin protein level with lithium treatment
(p < 0.01) and a decrease to 45% of control levels with
Dkk-1 treatment (P < 0.005).
Human fibroblasts behave the same as murine cells
To determine if human cells behaved the same as cells
from mice, we examined human primary fibroblasts in a
similar manner. Contraction was compared between cells
treated with transforming growth factor β, Dkk-1, lithium,
these agents in combination, or with controls. A similar
pattern as found in the mouse cultures was observed. Lith-
ium and Dkk-1 have a mild effect on lattice contraction,
while transforming growth factor β has a more dramatic
positive effect (Fig. 5). Dkk-1 and lithium had similar
effects as in murine cultures, showing a mild negative
effect of β-catenin on lattice contraction.
Transforming growth factor β induces collagen lattice con- traction independent of β-catenin Figure 2
Transforming growth factor β induces collagen lat-
tice contraction independent of β-catenin. A Means 
and 95% confidence intervals for collagen lattice mean diame-
ter as observed over seven days for fibroblasts from mice 
expressing null β-catenin alleles or wild type littermates 
treated with the adenovirus expressing cre recombinase also 
treated with transforming growth factor β, or the carrier. 
There is a statistically significant difference between trans-
forming growth factor β and carrier treatment for time 
points identified with an asterisk above the point, but no sta-
tistically significant difference between fibroblasts in which 
the β-catenin null allele was activated compared to treatment 
with transforming growth factor. Data is shown in the 
absence of serum. B. Representative photographs of the col-
lagen lattices at day seven.
β-catenin stabilization has a minor effect on collagen lattice  contraction compared to transforming growth factor β Figure 3
β-catenin stabilization has a minor effect on collagen 
lattice contraction compared to transforming 
growth factor β. A. Means and 95% confidence intervals for 
collagen lattice areas as observed over seven days for fibrob-
lasts from mice expressing stabilized β-catenin alleles or wild 
type littermates treated with the adenovirus expressing cre 
recombinase, also treated with either transforming growth 
factor β, or carrier. There is a statistically significant differ-
ence between transforming growth factor β and carrier 
treatment for all time points after day three, and a statisti-
cally significant difference between fibroblasts in which the 
stabilized β-catenin allele was activated compared to fibrob-
lasts from wild type mice for the time points with an asterisk 
above the data points. Data obtained using serum free media 
is shown. B. Representative photographs of the collagen lat-
tices at day seven.BMC Cell Biology 2009, 10:38 http://www.biomedcentral.com/1471-2121/10/38
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β-catenin, but not transforming growth factor β, positively 
regulates fibroblast cell motility
The scratch wound assay can be used to study cell migra-
tion, and approximates some of the conditions present
during wound repair [4]. Using this assay, we found a pos-
itive correlation between β-catenin levels and the rate of
cell migration across the scratch wound. Transforming
growth factor β had little effect on fibroblast motility
using this assay (Fig. 6). Motility was also measured using
Boyden chambers. The number of cells moving across the
membrane per high powered field correlated with β-cat-
enin level, with cells expressing the stabilized form of β-
catenin having an average of 11.2 cell per high powered
field, wild type cells 8.6 cells per high powered field, and
4.3 cells per high powered field in cells expressing a null
allele of β-catenin (p < 0.01). Transforming growth factor
β did not change the number of cells crossing the mem-
brane in the Boyden chamber. In contrast to their ability
to induce lattice contraction, β-catenin positively regu-
lates cell motility, while transforming growth factor β
plays little role in this process.
Transforming growth factor β, but not β-catenin, regulates 
α-smooth muscle actin expression
α-smooth muscle actin can regulate fibroblast contrac-
tion, and the expression of this gene is known to be regu-
lated by transforming growth factor β [30,31]. As such, we
examined the regulation of α-smooth muscle actin expres-
sion by β-catenin and transforming growth factor β using
quantitative RT-PCR in cells grown on plastic tissue cul-
ture dishes. Transforming growth factor β treatment
increased α-smooth muscle actin expression more than
two-fold (Fig. 7). In contrast, the level of expression did
not change significantly in cells expressing stabilized or
null alleles of β-catenin.
Discussion
During wound repair, fibroblasts move across tissue
defects, and cause contraction of the extracellular matrix.
Fibroblast motility is initiated when a cell extends a pro-
trusion at its front which attaches to the substratum on
which the cell is migrating, followed by a contraction that
moves the cell body forward toward the protrusion, and
finally the attachments at the cell rear release as the cell
moves forward. The ability of fibroblasts to induce con-
traction of a collagen lattice is related to activation of
fibroblast contractile machinery, the ability to transmit
the contractile force to the extracellular matrix, and to the
remodeling of the matrix. We found that different signal-
ing pathways regulate these processes, suggesting that
these two processes are controlled by different intracellu-
lar mechanisms.
Fibroblast activation to myofibroblasts is mediated by α-
smooth muscle actin, and can be induced by transforming
growth factor β. This is one mechanism by which trans-
forming growth factor β can activate the fibroblast con-
tractile machinery [11,32]. We found that in contrast to
transforming growth factor β, β-catenin does not regulate
α-smooth muscle actin expression. This finding that is
consistent with data from human wound healing.
Although α-smooth muscle actin is elevated during the
wound healing process, its expression does not vary sig-
nificantly during the first few weeks of wound repair, a
time during which β-catenin level shows substantial vari-
ation[14]. Taken together, this suggests that β-catenin
mediated tcf-dependent transcription does not directly
regulate α-smooth muscle actin expression in fibrobasts.
We found little effect of transforming growth factor β on
fibroblast motility. This is in agreement with studies sug-
gesting an inhibitory effect of transforming growth factor
β on fibroblast motility [13,33]. However, transforming
growth factor β has also been shown to activate cell motil-
ity on certain cell surfaces [34]. This suggests that it has
different effects depending on the environment in which
the fibroblast resides. In contrast to transforming growth
factor β, β-catenin was found to positively regulate cell
motility. Our findings are in agreement with developmen-
tal data, in which canonical Wnt signaling can regulate
cell migration, such as in cardiac progenitors, whose
migration is controlled by β-catenin signaling [35]. Cell
motility is an integral process in wound repair, as cells
need to migrate to cross the tissue defect. This is a complex
process, during which a cell extends a protrusion at its
front, which in turn attaches to the substratum on which
the cell is migrating. This is followed by a contraction that
moves the cell body forward toward the protrusion, and
finally the attachments at the cell rear release as the cell
continues to move forward. Chemotactic agents initiate
this cycle, and intracellular processes, such as actomyosin
filament contraction, which proposes the cell forward,
and the formation of adhesive connections in the front,
and release of adhesion in the rear of the cell are respon-
sible for propelling the cell. β-catenin participates in adhe-
rens junctions, actin cytoskeleton binding, and
transcriptional regulation. Participation in each of these
processes could regulate cell migration[34].
During wound repair, numerous factors contribute to
wound size including the number of cells present (a func-
tion of cell proliferation and migration) and the behavior
of the cells within the extracellular matrix. Activation of
number of signaling pathways, such as through trans-
forming growth factor β and β-catenin, cause a larger
wound size. Our data, in concert with data from previous
studies, suggests that these two signaling pathways acti-
vate different cellular processes to produce a larger wound
size. Both transforming growth factor β and β-catenin pos-
itively regulate fibroblast proliferation, suggesting that
this is a common cellular process in the generation of a
hypertrophic wound. In contrast β-catenin has a domi-BMC Cell Biology 2009, 10:38 http://www.biomedcentral.com/1471-2121/10/38
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nant role regulates cell motility while transforming
growth factor β has a dominant role regulating lattice con-
traction. Such data likely has important implications in
therapeutic approaches to hyperplasic wound healing, as
the modulation of a multiple involved signaling pathways
may be required.
Conclusion
Cutaneous wound healing is a complex process involving
multiple cell types and intracellular signaling pathways. β-
catenin and transforming growth factor β play important
roles in this process, both of which positively regulate
wound size. Here we show that transforming growth fac-
tor β plays a major regulatory role, while β-catenin plays a
minor role regulating contraction of a floating collagen
lattice. In contrast, we found little effect of transforming
growth factor β on fibroblast motility, while β-catenin
plays a significant role positively regulating fibroblast cell
migration. Although β-catenin partially mediates the
effect of transforming growth factor β on cell proliferation
[16] in fibroblasts, it does not mediate the effect of trans-
forming growth factor β on the induction of contraction
of collagen lattices. This demonstrates the complexity of
the interaction of various signaling pathways in the regu-
lation of cell behavior in wound repair, that cell motility
and the induction of collagen lattice contraction are likely
controlled by different intracellular mechanisms, and sug-
gests that there is unlikely to be a single signaling pathway
which will act as master regulator of fibroblast behavior in
wound repair.
Methods
Primary Cell Cultures
Primary cell dermal fibroblast cell cultures were estab-
lished from mice or from patients undergoing surgery as
previously reported[22,36,37]. In the case of human sam-
ples, cultures from three independent patients were inves-
tigated. All primary cultures were studied within their first
three passages. To examine the role of β-catenin, primary
fibroblast cell cultures derived from mice expressing β-cat-
enin conditional stabilized or null alleles were utilized.
Catnbtm2Kem mice contain β-catenin alleles with loxP sites
flanking exons 1 and 6. When the segment between loxP
sites is excised by exposure to cre-recombinase this effec-
tively abolishes the ability to express β-catenin pro-
tein[38]. The Catnblox(ex3) mouse harbors a conditional β-
catenin allele containing loxP sites flanking exon three.
Dkk-1 and lithium have a minimal effect on collagen lattice  contraction Figure 4
Dkk-1 and lithium have a minimal effect on collagen 
lattice contraction. A. Means and 95% confidence intervals 
for collagen lattice average diameters as observed over seven 
days are given for fibroblasts from mice expressing the wild 
type fibroblasts treated with either an adenovirus expressing 
Dkk-1 or a control adenovirus. Cultures were also treated 
with either transforming growth factor β or a carrier. There 
is a statistically significant difference for transforming growth 
factor β treatment compared to carrier after day three. For 
Dkk-1 and lithium treatment there is a minimal change in lat-
tice contraction rate. B. Representative photographs of the 
collagen lattices at day seven. C. Western analysis for β-cat-
enin showing how Dkk-1 and lithium regulates the protein 
level of β-catenin.
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Human fibroblasts induce collagen lattice contraction in a  similar manner as murine firoblasts Figure 5
Human fibroblasts induce collagen lattice contrac-
tion in a similar manner as murine firoblasts. A. Means 
and 95% confidence intervals for collagen lattice areas as 
observed over seven days are given for primary cultures 
from human fibroblasts treated with lithium, Dkk-1, TGF-β, 
or a carrier. There is a statistically significant difference for 
TGF-β treatment compared to carrier after day three. For 
lithium treatment there is a statistically significant difference 
for the time points with an asterisk above the data points. B. 
Representative photographs of the collagen lattices at day 
five.BMC Cell Biology 2009, 10:38 http://www.biomedcentral.com/1471-2121/10/38
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β-catenin positively regulates cell motility in the scratch assay, while transforming growth factor β has little effect Figure 6
β-catenin positively regulates cell motility in the scratch assay, while transforming growth factor β has little 
effect. A. The means and 95% confidence intervals of the average distance between cells on either side of the scratch (mm). 
Statistically significant differences (p < 0.05) compared to the controls are indicated with an asterisk above the bar. B through 
E. Representative photomicrographs of the gap in the cell cultures. B is from wild type cells, C from cells expressing null β-cat-
enin alleles, D from cells treated with transforming growth factor β, and E is from cells expressing stabilized β-catenin alleles. F. 
The means and 95% confidence intervals of the number of cells passing through the membrane in the Boyden chamber. Statis-
tically significant differences (p < 0.05) compared to the controls are indicated with an asterisk above the bar.
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
 
!
"
#
$
%
&
&
’

Ğ
ů
ů
Ɛ

Ɖ
Ğ
ƌ

Ś
ŝ
Ő
Ś

Ɖ
Ž
ǁ
Ğ
ƌ

Į
Ğ
ů
Ě
(
(
(
(
(
(
(
(BMC Cell Biology 2009, 10:38 http://www.biomedcentral.com/1471-2121/10/38
Page 8 of 10
(page number not for citation purposes)
When exposed to cre-recombinase, this results in expres-
sion of a functional β-catenin protein that is missing the
amino terminal phosphorylation sites and as such is a
constitutively stabilized, transcriptionally active pro-
tein[24]. This research was performed with the approval
of an appropriate human and animal ethics committee at
our institution.
Treatments to modulate transforming growth factor β and 
β-Catenin activity
To drive cre-recombinase expression in the murine fibrob-
last cells, we used an adenovirus engineered to expresses
cre-recombinase (Ad-cre)[16]. Primary cell cultures were
infected with 108 PFU of the virus as in our previous work.
In cells from the Catnbtm2Kem mouse, this did not com-
pletely abolish β-catenin protein level, but reduced the
level of to about one third of control levels, and in cells
from the Catnblox(ex3) mouse, treatment doubled the β-cat-
enin protein level. To determine if Wnt ligands are
required play a role in the regulation of the lattice contrac-
tion, we treated cells with a dickkopf-1 (Dkk1) expressing
adenovirus (Ad-Dkk1) as previously reported [29]. Dkk-1
is a potent secreted Wnt antagonist that interacts with Wnt
coreceptors of the LRP family[39]. Ad-Dkk1 treatment
effectively blocks Wnt mediated signaling during mesen-
chymal repair processes[40,41]. An adenovirus expressing
an empty vector was used as a control. To pharmacologi-
cally increase β-catenin protein level, we treated the cells
with lithium as previously reported [16,40]. Lithium ele-
vates β-catenin level through regulation of GSK3β[25,26].
Sodium was used as a control. Transforming growth factor
β one (Sigma), was added to cultures at a concentration of
10 ng/ml, a concentration that induces maximal effects on
the regulation of cell contraction and proliferation in
fibroblast cells [42,43].
Collagen lattice contraction assays
Collagen lattice contraction assays were carried out using
murine or human primary cell cultures. The cultures were
grown as three dimensional Fibroblast Populated Colla-
gen Lattices (FPLCs). Collagen lattices were prepared by
mixing cells with a neutralized solution of collagen type I
(8 parts PureCol collagen type I, 2.9 mg/ml, Inamed Bio-
Materials, Fermont, CA, plus one part 10× α-MEM + 1 part
0.2 M HEPES buffer, pH 9). Final collagen and cell con-
centrations for the FPCL were 2.0 mg/ml and 3 × 105cells/
ml of matrix, respectively. The cell-collagen mixture was
aliquoted into 24 well culture dishes (0.5 ml/well) that
were pre-treated with a PBS + 2% BSA solution. α-MEM,
with or without 10% fetal calf serum (FCS) was added
atop FPCLs in each well after polymerization. The
attached FPCL were mechanically released from the sides
of the culture plates. Digital images of the contracting
FPCL were captured at various time points over 7 days
using a conventional flatbed Cannon scanner. Average
collagen lattice diameter was then measured using imag-
ing software (technique modified from Howard et al
[44,45]). At the end of the contraction experiment, the
collagen lattices were digested with 1000 units/ml Colla-
genase I (Worthington -Biochemical Corporation), and
cells were isolated and lysed. Total β-Catenin level was
examined using western blot, and relative cell number
determined using DNA content as previously described
[15]. Each individual experiment was performed in at
least triplicate, and for each set of conditions the experi-
ment was performed five times. Means, standard devia-
tion, and 95% confidence intervals for the area of the
lattices were calculated for each cell type and treatment
group, which were then compared using the student t-test.
Scratch and chemotaxis assays
1.0 × 104 cells were seeded into 35-mm plastic tissue cul-
ture plates. Confluent monolayers were obtained after
three days, afterwhich the cells were incubated for 12
hours in serum free media. A "scratch" in the middle of
the cell monolayer was produced using a 1 mm wide cell
scraper. Cells were observed immediately after the gener-
ation of the scratch to ensure a uniform 1 mm wide
"scratch" region. They were then observed again 24 hours
later to measure the average distance between the cells on
each side of the scratch as previously reported [4]. Chem-
otaxis was measured using primary cell cultures in a mod-
ified Boyden chamber as previously reported[36]. A 6-mm
Nucleopore membrane (Millipore, Bedford, MA) was
Transforming growth factor β, but not β-catenin regulates  the expression of alpha smooth muscle actin Figure 7
Transforming growth factor β, but not β-catenin reg-
ulates the expression of alpha smooth muscle actin. 
Mean and 95% confidence intervals for the relative expres-
sion of alpha smooth muscle actin. Treatment with trans-
forming growth factor β resulted in a significantly different 
level of expression, while activation of conditional alleles of 
β-catenin had little effect. An asterix above the data point 
indicates a significant difference from the control value.BMC Cell Biology 2009, 10:38 http://www.biomedcentral.com/1471-2121/10/38
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placed between the microchemotactic chambers. Cell cul-
ture medium with transforming growth factor β, lithium,
or Dkk-1 was placed in the lower portion of the chamber.
An equal number of cells were placed into the upper
chamber for each experiment. Cell migration was deter-
mined by counting the number of cells that migrated to
the lower portion of the Nucleopore filter over 10 high-
power fields. At the end of each experiment the number of
cells on the slide (in the case of the scratch assay) or on the
top of the Nucleopore membrane in the microchemotac-
tic chambers was counted over ten high powered fields,
and no differences in cell numbers were observed between
any of the experimental conditions.
Real time PCR
Real time PCR was used to determine differences in alpha
smooth muscle actin using previously reported tech-
niques[46]. Cells derived from genetically modified mice
or wild type littermates were examined 24 hours after
treatment with the adenovirus or transforming growth
factor  β. Cells were grown on tissue culture plastic in
serum free media for 24 hours. Primers and probes for
mouse alpha smooth muscle actin, and 18s rRNA were
obtained from Applied Biosystems and used according to
the manufacturer's instructions. Quantitative values of
alpha smooth muscle actin is normalized based on 18s
rRNA content.
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